User: Guest  Login
More Searchfields
Simple search
Document type:
Correction; Published Erratum
Author(s):
Schneeweiss, Andreas; Ettl, Johannes; Lüftner, Diana; Beckmann, Matthias W; Belleville, Erik; Fasching, Peter A; Fehm, Tanja N; Geberth, Matthias; Häberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D; Hielscher, Carsten; Huober, Jens; Ruckhäberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christian; Kurbacher, Christian M; Klein, Evelyn; Lux, Michael P; Müller, Volkmar; Nabieva, Naiba; Overkamp, Friedrich; Tesch, Hans; Laakmann, Elena; Taran, Florin-Andrei; Seitz, Julia; Thomssen, Christoph; Untch, M...     »
Title:
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany".
Journal title abbreviation:
Breast
Year:
2021
Journal volume:
55
Pages contribution:
138-139
Fulltext / DOI:
doi:10.1016/j.breast.2020.12.007
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/33413981
Print-ISSN:
0960-9776
TUM Institution:
597; Frauenklinik und Poliklinik
 BibTeX